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Available online 2 March 2011Abstract Pancreatic β-cells function optimally when clustered in islet-like structures. However, nutrient and oxygen
deprivation limits the viability of cells at the core of excessively large clusters. Hence, production of functional β-cells from
human embryonic stem cells (hESCs) for patients with diabetes would benefit from the growth and differentiation of these
cells in size-controlled aggregates. In this study, we controlled cluster size by seeding hESCs onto glass cover slips patterned by
the covalent microcontact-printing of laminin in circular patches of 120 μm in diameter. These were used as substrates to
grow and differentiate hESCs first into SOX17-positive/SOX7-negative definitive endoderm, after which many clusters
released and formed uniformly sized three-dimensional clusters. Both released clusters and those that remained attached
differentiated into HNF1β-positive primitive gut tube-like cells with high efficiency. Further differentiation yielded
pancreatic endoderm-like cells that co-expressed PDX1 and NKX6.1. Controlling aggregate size allows efficient production of
uniformly-clustered pancreatic endocrine precursors for in vivo engraftment or further in vitro maturation.
© 2011 Elsevier B.V. All rights reserved.mellitus). Transplantation of cadaveric pancreata or the β-Introduction
The elevated blood glucose that characterizes diabetes
mellitus results from the loss of insulin-producing β-cells
from the islets of Langerhans in the pancreas (type 1 diabetes
mellitus) or from a relative deficiency of insulin production
in a setting of reduced insulin sensitivity (type 2 diabetes⁎ Corresponding author at: Diabetes Center, University of Califor-
nia San Francisco, 35 Medical Center Way, San Francisco, CA 94143,
USA. Fax: +1 415 731 3612.
E-mail address: mgerman@diabetes.ucsf.edu (M.S. German).
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doi:10.1016/j.scr.2011.02.004cell-containing islets thereof offers the only cure for patients
dependent on exogenous insulin (Shapiro et al., 2000).
However, immune-mediated damage to the transplanted β-
cells and insufficient revascularization (Lau and Carlsson,
2009) leading to nutrient and oxygen-deprivation, especially
inside large islets, limits islet survival. As a consequence, the
long-term benefits of these grafts are limited; most recipients
remain insulin-independent for less than two years (Ryan et
al., 2005). Besides, current numbers of donor organs cannot
provide enough material for all patients.
The potential of human embryonic stem cells (hESCs) to
differentiate into any somatic cell type, including glucose-.
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a possible solution to the shortage of transplantable cells.
Unfortunately, current in vitro differentiation protocols do
not generate homogeneous populations of functional β-cells
(for review, see Van Hoof et al., 2009a). Furthermore, these
protocols rely on consecutive exposures of hESCs to various
factors, either in an adherent monolayer format or after an
embryoid body-formation step, which is associated with
spontaneous differentiation into various undesired cell
types. In addition, the size of end-stage clusters varies
greatly, and is difficult to control.
The sensitivity of β-cells to external glucose levels, and
their responsive insulin release, is highly dependent on cell-
cell contact. Notably, clusters comprising multiple β-cells
have a greater glucose-stimulated insulin release than single
β-cells (Meda et al., 1990; Jaques et al., 2008). Furthermore,
β-cells secrete more insulin when in three-dimensional
aggregates than in monolayers (Brereton et al., 2006). In
addition, nutrient deprivation is observed in transplanted
islets with diameters exceeding 100 μm (Lehmann et al.,
2007). Therefore, hESC-derived β-cells will most likely
function optimally after transplantation when clustered in
multicellular structures that are approximately 100 μm in
diameter, a size that is large enough for efficient glucose-
responsive insulin secretion, yet small enough to prevent
nutrient starvation of cells residing in the core.
Here, we report a procedure to derive definitive endoderm
cells from hESCs with high efficiency, while culturing them on
covalently-bound laminin circular patches of 120 μm in
diameter. Subsequent exposure to keratinocyte growth factor
converted these adherent aggregates into highly homogeneous
clusters comprising mainly HNF1β+ primitive gut tube-like
cells. Furthermore, cells in these clusters differentiated into
PDX1+/NKX6.1+ pancreatic endoderm upon consecutive expo-
sure to additional factors. In addition, the primitive gut tube-
like clusters could be dislodged mechanically, without
enzymatic treatment, after which they balled up into uniform
~100 μm-diameter spheres that retained the ability to form
pancreatic endoderm-like cells co-expressing PDX1 and
NKX6.1. Since the size of transplanted islets impacts insulin
secretion and viability (Lehmann et al., 2007), the generation
of hESC-derived pancreatic progenitors in spherical clusters of
controllable size and cell number could, as proof of concept,Figure 1 hESCs grown on laminin- or Matrigel-coated glass retain
shown for OCT4 (green) in hESCs that were plated without feeder ce
ToPro3 is shown in blue. Scale bar, 100 μm.contribute to developing a renewable, long-lasting treatment
for type I diabetes.Results
Maintenance of hESCs on laminin-coated glass cover
slips
To develop methods for growing hESCs in controlled cluster
sizes, we first tested for culturing conditions that allowed for
adherence and growth on glass cover slips in the absence of
MEFs. Since hESCs have an epithelial character (Van Hoof et
al., 2008) and express integrins α2, α6, β1, and β4 (Van Hoof
et al., 2006, 2009b; Dormeyer et al., 2008), laminin was
chosen for a scaffold protein. Glass cover slips were coated
non-covalently with laminin or laminin-containing Matrigel in
the absence of MEFs.
Static water contact angle measurements were per-
formed by a technique that assesses the hydrophobicity of
a surface to verify laminin attachment. Clean, dry, plasma-
treated cover slips are hydrophilic and exhibited water
contact angles near zero degrees (n=3). Laminin or matrigel
coating rendered the surfaces more hydrophobic and
resulted in water contact angles of 30.7±1.2 and 30.0±1.0,
respectively (n=3). Since laminin is the dominant matrix
component of Matrigel, their water contact angles are
expected to be similar.
The buoyancy of the generally hydrophobic laminin-
coated cover slips was reduced by incubating them overnight
in serum-containing medium, which coincidentally increased
the affinity of the hESCs for the treated cover slips. Using
these laminin-coated surfaces and MEF-conditioned medium
supplemented with FGF2, hESCs could be maintained for at
least three days without loss of the pluripotency marker
OCT4 (Fig. 1). Similar results were obtained with cover slips
coated with Matrigel, gelatin, collagen I, or fibronectin
(Supplemental Figs. 1A–D); however, cell densities were
highest with laminin-coated cover slips. This difference in
cell density may have resulted from a higher fraction of cells
attaching to the laminin-coated surface than to the Matrigel-
coated surface after passaging.OCT4 expression. Confocal fluorescence microscopic imaging is
lls on glass cover slips coated with laminin. Nuclear staining with
278 D. Van Hoof et al.Maintenance of hESCs on microcontact-printed glass
cover slips
To control cluster size, glass cover slips were microcontact-
printed with covalently-bound laminin in circular patterns of
120 μm in diameter with a spacing of 200 μm in between.
Because laminin attachment quenches the aldehydes on the
glass surface, and laminin binds poorly to BSA (Mendelsohn et
al., 2010), FITC-BSA incubation at 50 μg/ml for 20 min
enabled visualization of the unquenched aldehydes on the
glass surface between the patterns and confirmed correct
laminin patterning (Figs. 2A and B). Finally, to render the
glass surface in between the patterns resistant to cell
attachment, the remaining aldehydes were then passivated
with mPEG-amine. Thorough characterization of cover slips
patterned with this method and each step in the functiona-
lization process have been reported previously (Mendelsohn
et al., 2010).
After laminin-patterning and mPEG-amine attachment,
hESCs were seeded without MEFs on the cover slips at a
density of 25,000 cells/cm2, which corresponds to an
effective seeding density of ~28,000 cells per microcontact-Figure 2 hESCs grown on patches with microcontact-printed lamin
FITC-BSA bound to the surface between the microcontact-printed
organization (A and B). Feeder-free hESCs grown for three days
pluripotency marker OCT4 (C and D, green) but did not express the e
shown in blue. Scale bars, 100 μm.printed glass cover slip. After three days in culture, the
patches averaged 36.2 cells (SD=11.2, n=86) growing in
compact colonies. The cells in these adherent clusters were
positive for the pluripotency marker OCT4, but negative for
the endoderm marker SOX17 (Figs. 2C and D). When
maintained on these laminin patches for more than three
days, the cells continued to proliferate (cells in the
metaphase and anaphase can be discerned in Fig. 2D, top
left panel), forming multi-layered cell aggregates that
outgrew the 120 μm circular patches and detached during
medium refreshment over the next few days.
Differentiation of hESCs on microcontact-printed
glass cover slips
Activin A is known to be a potent component for the
differentiation of hESCs into definitive endoderm (D'Amour
et al., 2005). First, we tested whether hESCs could
differentiate into definitive endoderm when using medium
conditioned by activin A-secreting CHO cells (Arai et al.,
2006) instead of medium supplemented with purified activin
A. Subjecting hESCs that were grown on gelatin-coatedin retain OCT4 expression. Fluorescence microscopic imaging of
120 μm-diameter circular laminin patches verifies the pattern
on these laminin-coated patches retained expression of the
ndoderm marker SOX17 (D, red). Nuclear staining with ToPro3 is
Figure 3 Differentiation of hESCs into definitive endoderm with high efficiency. Flow cytometry analysis of hESCs that were
differentiated for three days (A and B) shows that OCT4 expression sharply decreased, and SOX17 emerged, when the hESCs were
incubated for three days with medium conditioned by activin A-secreting CHO cells (B). In contrast, OCT4 expression was retained
when hESCs were differentiated in unconditioned medium (A). Confocal laser scanning microscopy confirmed the differentiation of
the treated cells, showing that only a few cells expressed OCT4 (C, green), while the majority upregulated SOX17 (C, red). (C) Nuclear
staining with ToPro3 is shown in blue. Scale bars, 100 μm.
279Size-controlled hESC-derived pancreatic endodermculture plastic to this modified Stage 1 generated definitive
endoderm with high efficiency. At the end of day 3, ~84% of
the cells stained for the endoderm marker SOX17 (Fig. 3A) as
assessed by flow cytometry, and few of these SOX17+ cells
(~2.5%) retained high levels of the pluripotency marker
OCT4. In contrast, the majority of untreated cells grown
under control conditions in unconditioned medium for the
same period continued to express high levels of OCT4, and
only ~1% expressed SOX17 (Fig. 3B). Analysis of the treated
cells by immunofluorescence microscopy confirmed these
flow cytometry data, showing rare OCT4+ cells scattered
among the SOX17+ majority (Fig. 3C).
RNA expression analysis by real-time RT-PCR confirmed
that the hESCs had differentiated into definitive endoderm.
After 3 days of treatment, OCT4 transcript levels fell
dramatically (Supplemental Fig. 2A), whereas SOX17 (Sup-
plemental Fig. 2B) and FOXA2 (Supplemental Fig. 2C) mRNA
levels increased; SOX7mRNA levels were very low in hESCs as
well as in the differentiated cells (Supplemental Fig. 2D),
indicating that the cells had converted to definitive
endoderm rather than visceral endoderm.
Since this differentiation procedure efficiently generated
definitive endoderm, we applied the same conditions to the
hESCs grown on microcontact-printed cover slips 72 h after
plating. When subjected to the conditions for Stage 1, all the
cells in each adherent cluster expressed SOX17 on the third
day, whereas OCT4 staining was reduced to nearly unde-
tectable levels (Fig. 4A).
The Stage 1 cells growing on microcontact-printed cover
slips were then sequentially subjected to the succeedingdifferentiation stages to move them along the pancreatic
differentiation lineage. Expression of HNF1β, a marker of the
primitive gut tube (i.e. Stage 2), was observed when the cells
from Stage 1 were incubated for 3 days with KGF (Fig. 4B).
Upregulation of HNF1β was associated with a reduction in
SOX17 levels, as has been reported previously (D'Amour et
al., 2006). Notably, the liver marker albumin was not
detected (inset in Fig. 4B), suggesting that these cells were
not committed to the hepatic lineage.
To further differentiate these cells along the pancreatic
pathway to Stage 3 cells, they were incubated for 3 days with
a combination of (–)-indolactam V, FGF10, BSA-V, and N2
(Chen et al., 2009). Not all the cells positive for HNF1β co-
expressed PDX1 at the end of Stage 3 (Fig. 4C), suggesting
that only a portion of these cells had adopted posterior
foregut-like properties.
During Stage 4, the cells were maintained in B27-
containing medium, resulting in the appearance of NKX6.1+
cells among those positive for PDX1 (Fig. 4D). Pancreatic
endoderm cells, marked by the co-expression of PDX1 and
NKX6.1, were rare and limited to one or two cells per cluster.Suspension growth and adherence of detached
definitive endoderm clusters
Although some clusters remained attached throughout the
entire differentiation protocol, the majority detached after
Stage 1. The spherical clumps of cells had a uniform diameter
of approximately 100 μm (Fig. 5A). When transferred to low-
Figure 4 Differentiation of hESCs into pancreatic endoderm on circular laminin-coated patches. Confocal microscopic imaging
demonstrates hESCs growth and differentiation on circular laminin-coated patches of 120 μm in diameter (A–D). (A) At Stage 1, the
cells differentiated to definitive endoderm, as shown by downregulation of OCT4 (green) and upregulation of SOX17 (red). Most of the
cells adopted primitive gut tube-like characteristics by the end of Stage 2 (B), as evidenced by upregulation of HNF1β (green),
reduction in SOX17 expression (red), and absence of ALB (inset in bottom-left panel; grey). (C) At Stage 3, some of the HNF1β+ cells
(green) co-expressed PDX1 (red), thereby resembling posterior foregut cells. Pancreatic endoderm-like cells, marked by the co-
expression of NKX6.1 (green) and PDX1 (red) were seen at Stage 4 (D), and usually occurred as single cells (indicated by an arrow in the
bottom right panel) or doublets (inset in bottom right panel) in the clusters. Nuclear staining with ToPro3 (top left, bottom left, and
bottom right panels) and DAPI (top right panel) is shown in blue. Scale bars, 100 μm.
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the cells in these clusters expressed HNF1β (Fig. 5B), as
observed for the adherent clusters (Fig. 4B). Three-dimensional
analysis revealed that essentially all cells in these spherical
structures adopted a primitive gut tube-like identity (Fig. 5C
and Supplemental online video 1), suggesting that Stage 2
differentiation in suspension is as efficient as that for adherent
cells.Figure 5 Suspension differentiation of hESCs into primitive gut t
bright-field microscopic image is shown of differentiating cluste
microscopic images are shown at Stage 2 of a suspended cluster, all ce
(C) Side views of a 3-D reconstruction of a cluster similar to that sho
view. (D) A confocal microscopic image is shown of a cluster that wa
during Stage 2. Like others, cells from this cluster express HNF1β
structure. Nuclear staining with ToPro3 is shown in blue. Scale barsWhen kept in suspension for an extended time, while
proceeding to the subsequent stages, the clusters clumped
together, forming larger aggregates of various shapes and
sizes. In these suspended clusters, only a few PDX1+ cells
were found, some of which were positive for NKX6.1
(Supplemental Fig. 3). On the other hand, when the
suspended definitive endoderm clusters were allowed to
adhere, and were exposed to the conditions for Stage 3 forube cells, and into posterior foregut cells after replating. (A) A
rs that dislodged spontaneously after Stage 1. (B) Confocal
lls of which express HNF1β (green) and low levels of SOX17 (red).
wn in (B); the arrows aimed at the sphere indicate the point of
s plated at the onset of Stage 3 after having been in suspension
(green), with PDX1+ cells (red) at the center of the colony-like
, 100 μm.
281Size-controlled hESC-derived pancreatic endoderm
Figure 6 Differentiation of hESCs. Schematic overview of the differentiation procedure as described in the Materials and methods
section.
282 D. Van Hoof et al.three days, PDX1+ posterior foregut-like cells were localized
at the centers of the newly adherent clusters (Fig. 5D), and
were surrounded by an HNF1β+ monolayer. PDX1+ cells
residing in this HNF1β+ monolayer were scattered as single
cells or pairs, with the highest density close to the center.
Notably, these adherent clusters adopted a colony-like
architecture and had lost their original 100 μm-diameter
spherical shape.Discussion
After the demonstration of efficient formation of definitive
endoderm (D'Amour et al., 2005) and pancreatic endocrine
cells from hESCs, efforts have been focused on improving the
yield and purity of β-cell-like derivatives, resulting in diverse
protocols for generating insulin-producing cells (for reviews,
see Van Hoof et al., 2009a; Mfopou et al., 2010). However,
these insulin-producing cells differentiated in vitro from
hESCs do not secrete insulin in response to glucose as normal
β-cells do, and share characteristics with a terminal lineage
of pancreatic endocrine cells seen early in normal pancreatic
development. Only when transplanted at the pancreatic
endoderm-equivalent stage (Stage 4) and maintained for
several months, do in vitro-generated endocrine precursors
mature into glucose-responsive insulin-secreting cells exhi-
biting characteristics of true β-cells (Kroon et al., 2008). The
failure of the in vitro protocols to generate true β-cells could
result from the absence of interacting cells from other
lineages (mesoderm and ectoderm) present in the develop-
ing pancreatic bud during normal embryonic development of
the pancreas. Remarkably, the site of transplantation did not
make any substantial difference in the efficacy of pancreatic
endoderm maturation (Kroon et al., 2008), thus, a process as
simple as vascularization might be sufficient to allow the
generation of glucose responsive β-cells.
Although the site of transplantation may not have been
critical, the size of transplanted cell clusters was, since
150×150 μm chunks of in vitro-generated pancreatic endo-
derm gave optimal generation of physiologically regulated
β-cells in the transplantation model (Kroon et al., 2008). In
line with this observation, aggregated β-cells release insulin
more efficiently than do isolated β-cells (Meda et al., 1990;
Jaques et al., 2008), and they secrete more insulin from
three-dimensional aggregates as opposed to single layers ofcells (Brereton et al., 2006). The optimal cluster size for the
differentiation of functional β-cells from hESC-derived
pancreatic endoderm-like cells, while avoiding the starva-
tion of cells at the core, needs to be determined. Control of
cluster size can be achieved through the patterning of a
variety of materials, such as PVA (Cheng and LeDuc, 2006),
alkanethiolates (Mrksich et al., 1997), and laminin (Mendelsohn
et al., 2010). We tested several shapes (squares and circles),
sizes (ranging from 40 to 120 μm), arrangements (square grid
and triangular alignment), and distances between the patches.
We found that, if the patch surfacewas too small, the number of
cells that could adhere to the laminin competed for space; as a
result, the cell aggregates became multilayered and easily
detached from the patches during medium refreshment. On the
other hand, larger patches, generating clusters of more than
100 μm in diameter, were not desirable as pointed out above.
Furthermore, if the distance between the patches became too
small, the cells were able to bridge the PEGylated spaces in
between. In the end, 120-micron circles with 200-μm-gaps in a
triangular arrangement proved optimal. Our studies here
demonstrate the feasibility of controlling cell number as well
as colony shape and pattern, using covalently patterned
laminin, before initiating an in vitro differentiation procedure.
Moreover, this system readily allows further optimization and
adjustment of growth conditions (e.g. oxygen levels, media
additives, growth factors, etc.).
Transplantation of pancreatic endoderm generated from
hESCs or induced pluripotent cells with subsequent differen-
tiation to mature β-cells in vivo could be considered for the
treatment of diabetes in humans. However, our
current laboratory setting for generating cell clusters on
microcontact-printed surfaces would be difficult to expand
sufficiently to generate enough cells for human trials. In
addition to scale-up, preventing massive detachment of the
aggregates during the differentiation process would increase
the yield of transplantable material significantly. The
reduced affinity of the differentiating aggregates for the
microcontact-printed substrate may result from changes in
the range of anchoring proteins, such as integrins, expressed
as the cells undergo further differentiation. Knowledge of the
attachment proteins expressed by these cells could be used
with the microcontact-printed method to generate ideally
constituted and patterned growth surfaces.
Cell detachment may also result from a weakening of the
laminin from the glass cover slip. Previously, Fourier
283Size-controlled hESC-derived pancreatic endodermtransform infrared characterization on cover slips that were
patterned using this method verified the attachment of
laminin to the underlying aldehyde. However, in-depth
analysis of the spectrum revealed a significant spike, which
represents an amine, suggesting that multiple layers of
laminin had attached (Mendelsohn et al., 2010). As a result,
while a portion of the laminin had bound covalently, the rest
could have attached through weaker interactions. Although
to a lesser extent than was found in this study, we have
observed 832–13 insulinoma cells detaching from micro-
contact-printed laminin after several days in cell culture
conditions, and found that overlaying with low-melting point
agarose or other gels could hold the cells in place (data not
shown). However, these gels adhere poorly to the PEGylated
glass surface, and limit the diffusion of large molecules, like
growth factors. Alternatively, a protocol that allows effi-
cient differentiation in suspension once definitive endoderm
has been formed would overcome this problem entirely.
Conclusion
We have shown the utility of controlling cell cluster size in
differentiating hESCs into definitive endoderm and primitive
gut tube-like cells with high efficiency, and subsequent
differentiation into pancreatic endoderm. To do so, we
microcontact-printed patches of laminin onto glass cover
slips to serve as an attachment and growth substrate for the
hESCs. Optimization and scale-up of this process might yield
enough tissue for transplantation studies in diabetic mouse
models. Controlling cluster size promises to produce a
cellular architecture that enables sufficient nutrient avail-
ability as well as physiological insulin secretion. Microcon-
tact-printing provides a feasible approach to the production
of cell clusters of desired size for both optimal production
and post-transplantation function.
Materials and methods
Cleaning of glass cover slips
Glass cover slips were sonicated in a 70:30 ethanol:Milli-Q
water (Millipore, Bedford MA) solution for 10 min, then dried
with N2. Following this, cover slips were cleaned in oxygen
plasma at 175–200 W and 0.5 mTorr for 30 s (Plasmaline,
TCGAL Corporation).
Coating of cover slips
Clean dry plasma-treated glass cover slips were incubated
with 20 μg/ml Matrigel (BD Biosciences), mouse laminin
(Invitrogen), porcine gelatin (Sigma), rat tail collagen I
(Sigma) or human plasma fibronectin (Gibco) for 30 min.
Cover slips were then sonicated in phosphate-buffered saline
(PBS) for 5 min, rinsed with Milli-Q water and dried with N2.
Preparation of aldehyde-terminated glass cover
slips
Clean, dry, plasma-treated glass cover slips were silanized in
a freshly prepared solution of 2% APTES (v/v) in 95:5 ethanol:Milli-Q water for 30 min, followed by 10 dips in a freshly
prepared solution of 70:30 ethanol:Milli-Q water. The cover
slips were then submerged in a second freshly prepared
solution of 70:30 ethanol:Milli-Q water and sonicated for
20 s. Cover slips were dried with N2, and transferred to a
glass petri dish on a hot plate set to 120 °C for 1 h. The cover
slips were kept in a vacuum chamber at room temperature
for at least 24 h before use. The amine-terminated cover
slips were sonicated for 10 min in 70:30 ethanol:Milli-Q water
before incubation for 1 h at room temperature in 10%
glutaraldehyde in PBS. The aldehyde-terminated cover slips
were sonicated for another 10 min in 70:30 ethanol:Milli-Q
water, and then dried with a stream of N2.
Preparation of polydimethylsiloxane (PDMS) stamps
for microcontact printing of laminin
PDMS stamps were fabricated through a multi-step process
that uses photolithography and micropatterning techniques.
First, a negative photoresist SU-8 2010 was spin cast onto a
silicon wafer at 2000 rpm for 1 min, yielding a thickness of
approximately 13 μm as determined by profilometry (Ambios
XP-2, Ambiostech, Santa Cruz, CA). SU-8 films were pre-
baked on a hot-plate at 95 °C for 3 min. SU-8 films were
subsequently patterned by exposure to UV light through a
transparency mask defining 120 μm circles in a triangularly-
packed formation with 200 μm spacing in between the edges
of each pattern. Patterned SU-8 films were post-baked at
95 °C for 4 min and then immersed in SU-8 developer for
2 min to remove SU-8 that had not been crosslinked. Wafers
were subsequently rinsed with SU-8 developer, isopropyl
alcohol, and dried with a stream of N2. Last, the wafers were
baked at 150 °C for 15–20 min.
An inverse pattern of the silicon wafer was prepared with
PDMS. The base and curing agent were mixed at a 10:1 by
mass and deposited onto the micropatterned wafers. The
PDMS film was then de-gassed under vacuum for 1–2 h to
remove all bubbles, and cured at 70 °C for at least 2 h at
atmospheric pressure. Once cured, the PDMS was cut and
peeled from the silicon master.
Covalent attachment of laminin by microcontact
printing
Following exposure of PDMS stamps to O2 plasma for 30 s at
175–200 W and 0.5 mTorr, the surface was covered with a
solution of 200 μg/ml mouse laminin (1 mg/ml; Invitrogen) in
PBS and incubated for 30 min at room temperature. A Kimwipe
was used to wick away excess solution before drying the
remaining liquid with N2. Immediately after drying, the PDMS
stamps were carefully placed on the aldehyde-terminated
cover slip with a 10 g weight for 30 min at room temperature.
The stamps were carefully peeled off, leaving printed laminin.
Covalent attachment of PEG
After PDMS stamping of laminin, the cover slips were covered
with 25 μl of 3 mM mPEG-amine in methanol and excess
sodium cyanoborohydride (N8 mM) to quench unreacted
aldehyde groups. Cover slips were incubated for N12 h in a
chemical fume hood to vent hydrogen cyanide gas,
Table 1 RT-PCR primers.
OCT4 Forward: 5′-TGG GCT CGA GAA TGT G-3′
Reverse: 5′-GCA TAG TCG CTG CTT GAT CG-3′
SOX7 Forward: 5′-ACG CCG AGC TCA GCA AGA T-3′
Reverse: 5′-TCC ACG TAC GGC CTC TTC TG-3′
SOX17 Forward: 5′-GGC GCA CGA GAA TCC AGA-3′
Reverse: 5′-CCA CGA CTT GCC CAG CAT-3′
FOXA2 Forward: 5′-GGG AGC GGT GAA GAT GGA-3′
Reverse: 5′-TCA TGT TGC TCA CGG AGG AGT A-3′
GUSB Forward: 5′-ACG CAG AAA ATA TGT GGT TGG A-3′
Reverse: 5′-GCA CTC TCG TCG GTG ACT GTT-3′
284 D. Van Hoof et al.subsequently sonicated for 5 min in methanol, and rinsed
with methanol before being dried with N2.
Fluorescent imaging of cover slips
Cover slips that had been printed with laminin were exposed
to a 50 μg/ml fluorescein isothiocyanate-bovine serum
albumin (FITC-BSA) solution before PEG functionalization
for 20 min, sonicated in PBS for 5 min, rinsed with Milli-Q
water, and dried with N2. Images were taken with a wide-
field fluorescent microscope (Olympus BX60).
hESC culture and differentiation
Undifferentiated CyT49 hESC were grown as described
previously (D'Amour et al., 2006) with minor modifications
to the original protocol. The day before passaging hESCs,
mitomycin-C-treated mouse embryonic fibroblast feeder
cells (MEFs; Millipore Specialty Media) were plated onto
gelatin-coated (Sigma-Aldrich) 60 mm dishes (Falcon) at a
density of 5000 cells/cm2. Biweekly, the hESCs were
passaged enzymatically with Accutase (Esgro) according to
the manufacturer's protocol, and seeded at a density of
50,000–100,000 cells/cm2. Daily, the hESCs received fresh
hESC medium that was supplemented with 10 ng/ml FGF2
(R&D Systems), but did not contain activin A. Differentiation
was conducted in 12-well plates (Falcon) that contained the
microcontact-printed glass cover slips (Fisherbrand) de-
scribed above (Fig. 6). Prior to differentiation, the hESCs
were seeded at a density of 25,000 cells/cm2 in MEF-
conditioned hESC medium supplemented with 10 ng/ml
FGF2, and washed once with PBS 72 h post passaging.
Differentiation into definitive endoderm was carried out
using DMEM/F12 that was conditioned by CHO cells secreting
recombinant activin A (Arai et al., 2006). For the first 24 h,
this conditioned medium was supplemented with 2 mg/ml
bovine serum albumin fraction V (BSA-V; Sigma), 0.5×N2 and
0.5×B27 medium supplements (Invitrogen), 50 ng/ml Wnt3a
(R&D Systems), and 100 nM wortmannin (Sigma). Subse-
quently, the differentiating cells were incubated for an
additional 48 h in the medium described above, without
wortmannin and Wnt3a. To generate primitive gut tube-like
tissue, the cells were incubated for 72 h in RPMI 1640
(Invitrogen) with 2% (vol/vol) FBS (VWR Hyclone) and 50 ng/
ml KGF. For the generation of posterior foregut tissue, cells
at the primitive gut tube stage were incubated for 72 h in
DMEM/F12 with 1×N2, 300 nM (–)-indolactam V (Calbio-
chem), 2 mg/ml BSA-V, and 10 ng/ml FGF10 (R&D Systems).
To generate pancreatic endoderm, the posterior foregut
cells were incubated for 72 h in DMEM (Invitrogen) with
1×B27. Where indicated, the definitive endoderm-like
aggregates were dislodged from the microcontact-printed
cover slips by pipetting, transferred to low-attachment 12-
well plates (Falcon) to keep them in suspension, and
subjected to the differentiation procedure described
above. All media were refreshed daily.
Immunofluorescence microscopy
Cells were fixed and stained as described previously (Van
Hoof et al., 2009b), using the primary antibodies mouse anti-OCT4 (1:200; Santa Cruz), goat anti-SOX17 (1:1000, R&D
Systems), rabbit anti-HNF1b (1:100, Santa Cruz), mouse anti-
ALB (1:500, Sigma-Aldrich), goat anti-PDX1 (1:10,000,
Abcam), and mouse anti-NKX6.1 (1:50, Hybridoma F55A10-
c), in combination with the secondary antibodies FITC-
conjugated donkey anti-mouse, Cy3-conjugated donkey anti-
goat, FITC-conjugated donkey anti-rabbit (all 1:200, Jackson
ImmunoResearch Inc), and Alexa Fluor 647-conjugated
donkey anti-mouse (1:200, Invitrogen Life Technologies).
The cells were counter-stained with DAPI (Roche) or ToPro3
(Invitrogen Life Technologies) and mounted in VectaShield
(Vector Laboratories Inc). Images were captured using SL and
SP2 confocal laser scanning microscopes (Leica Microsys-
tems), and processed with Paint Shop Pro XI (Corel) and
ImageJ 1.43u to reconstruct the three-dimensional (3-D)
image of the cluster shown in Fig. 5C and Supplemental
online video 1.Flow cytometry
Cells were trypsinized and fixed as described (Van Hoof et
al., 2006), and permeabilized for 15 min in PBS with 0.4%
Triton X-100 and 1% BSA (Sigma-Aldrich). Then, the cells
were stained with the primary and secondary antibodies
indicated above, and sorted using an LSR II Flow cytometer
(BD Biosciences). The data were obtained with FACSDiva
6.1.3 (BD Biosciences), and processed with WinMDI 2.9.Quantitative real-time PCR
hESCs and definitive endoderm cells were collected from 12-
well plates (Falcon). RNA was extracted using TRIzol reagent
(Invitrogen). Concentrations of total RNA were measured
using the NanoDrop ND-1000 Spectrophotometer (NanoDrop
Technologies Inc), and 300–500 ng of this RNA was used in a
reverse transcription (RT) reaction with a Superscript III
cDNA Synthesis kit (Invitrogen). SYBR Green master mix
(Qiagen) RT-PCR reactions were set up in duplicate using
300–500 ng cDNA with 300 nM forward and reverse primers
summarized in Table 1 in an Applied Biosystems 7900.
Relative expression values were normalized relative to the
housekeeping gene GUSB, and the values from the definitive
endoderm samples were compared to those of the undiffer-
entiated hESCs.
Supplementary materials related to this article can be
found online at doi:10.1016/j.scr.2011.02.004.
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